MERIX Bioscience, Inc. Announces New Leadership And Board Members
10/19/2005 5:11:06 PM
Merix Bioscience, a company pioneering therapeutic immunotherapy vaccines, announced today that Lothar Finke, M.D., and Doug Winship, vice president of clinical development and vice president of quality and regulatory affairs, respectively, have joined the company. In addition, Merix welcomes Michel Greco and Richard Meadows to their board of directors.